Error: Could not add to watchlist. X
+ Watchlist

Novogen Ltd

NVGNF:US
OTC US
Price not available for NVGNF:US
USD
Volume
0
Previous Close
0.09
52Wk Range
0.09 - 0.14
Volume
0
Previous Close
0.09
52Wk Range
0.09 - 0.14
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
429.734
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
Address
16 - 20 Edgeworth David Ave
Hornsby, NSW 2077
Australia
Phone
61-2-9472-4100
Show More